Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new class of weight-loss drugs.
“Looking Good, Santa”: Elon Musk Admits To Using Mounjaro For Weight Loss In “Ozempic Santa” Post
Elon Musk uses the weight-loss drug Mounjaro, he newly revealed, as he jokingly referred to himself as “Ozempic Santa” in a Santa suit. Taking to the social media platform he owns, X (formerly known as Twitter),
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of himself wearing a Santa costume. "Ozempic Santa," the Tesla and SpaceX CEO posted alongside a photo of himself in the classic red outfit and white beard.
Elon Musk's 'Ozempic Santa' post turns heads, clashes with RFK Jr.'s stance
Elon Musk turned heads with a decadent his tree. Dressed head-to-toe in a Santa costume, he captioned his photo "Ozempic Santa," flaunting a slimmer figure. The Tesla CEO was picked by president-elect Donald Trump to co-lead the inaugural Department of Government Efficiency shortly after the election.
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,
Elon Musk Dramatically Puts MAGA Split With RFK Jr. on Display
Elon Musk has picked another fight in Donald Trump’s inner circle with a Christmas challenge to Robert F. Kennedy Jr. Musk posted a photo of himself on his platform X, formerly known as Twitter, dressed up as Santa Claus and posing in front of a lit-up tree with the caption: “Ozempic Santa.
Elon Musk admits to taking weight-loss drug while dressed as 'Ozempic Santa' on Christmas
Beyoncé Bowl halftime performance on Christmas Day 10 Supercars The New Corvette ZR1 Leaves In The Dust The bird at the center of the worst single-species mortality event in modern history isn’t recovering,
Elon Musk Shows Off His Mounjaro-Fueled Slimdown — in a Santa Suit
Musk posted a photo in a Santa suit to show his body transformation. He is posing with his hands on his hips in the red suit and a white Santa beard. While Santa is known for his
The Motley Fool on MSN4h
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Novo's Ozempic is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, while Wegovy is primarily ...
24/7 Wall St4h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
BizPac Review6h
Elon Musk jokes about being ‘Ozempic Santa’ with trimmed-down selfie
DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.
Benefits Pro6h
Medicaid spending on GLP-1s exceeded $3.5B in past year
California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.
For people who couldn’t get Ozempic or Wegovy, 2025 could be your year (if you can afford it)
It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...
dailymemphian3d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Tyler Morning Telegraph2h
Medicaid Now Covers GLP-1s for Obesity in Texas
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...